These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 24047962)
1. Production of anti-horse antibodies induced by IgG, F(ab')2 and Fab applied repeatedly to rabbits. Effect on antivenom pharmacokinetics. Vázquez H; Olvera F; Alagón A; Sevcik C Toxicon; 2013 Dec; 76():362-9. PubMed ID: 24047962 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab')(2), IgG and IgG(T) fragments from hyper immune equine plasma. Vázquez H; Olvera F; Paniagua-Solís J; Alagón A; Sevcik C Int Immunopharmacol; 2010 Apr; 10(4):447-54. PubMed ID: 20093203 [TBL] [Abstract][Full Text] [Related]
3. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid. Al-Abdulla I; Casewell NR; Landon J J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428 [TBL] [Abstract][Full Text] [Related]
4. Interspecies scaling of clearance and volume of distribution for horse antivenom F(ab')2. Bazin-Redureau M; Pepin S; Hong G; Debray M; Scherrmann JM Toxicol Appl Pharmacol; 1998 Jun; 150(2):295-300. PubMed ID: 9653060 [TBL] [Abstract][Full Text] [Related]
5. Snake antivenoms from hyperimmunized horses: comparison of the antivenom activity and biological properties of their whole IgG and F(ab')2 fragments. Morais JF; de Freitas MC; Yamaguchi IK; dos Santos MC; da Silva WD Toxicon; 1994 Jun; 32(6):725-34. PubMed ID: 7940578 [TBL] [Abstract][Full Text] [Related]
6. IgY pharmacokinetics in rabbits: implications for IgY use as antivenoms. Díaz P; Malavé C; Zerpa N; Vázquez H; D'Suze G; Montero Y; Castillo C; Alagón A; Sevcik C Toxicon; 2014 Nov; 90():124-33. PubMed ID: 25111201 [TBL] [Abstract][Full Text] [Related]
7. Snake F(ab')2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits. Pepin S; Lutsch C; Grandgeorge M; Scherrmann JM Pharm Res; 1995 Oct; 12(10):1470-3. PubMed ID: 8584483 [TBL] [Abstract][Full Text] [Related]
8. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration. León G; Segura A; Herrera M; Otero R; França FO; Barbaro KC; Cardoso JL; Wen FH; de Medeiros CR; Prado JC; Malaque CM; Lomonte B; Gutiérrez JM Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1115-9. PubMed ID: 18561967 [TBL] [Abstract][Full Text] [Related]
9. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions. León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538 [TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions. Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700 [TBL] [Abstract][Full Text] [Related]
11. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations. León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies. Welfringer F; d'Athis P; Scherrmann JM; Hervé F J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797 [TBL] [Abstract][Full Text] [Related]
13. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. Rivière G; Choumet V; Audebert F; Sabouraud A; Debray M; Scherrmann JM; Bon C J Pharmacol Exp Ther; 1997 Apr; 281(1):1-8. PubMed ID: 9103473 [TBL] [Abstract][Full Text] [Related]
14. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms. Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use. Ismail M; Abd-Elsalam MA Toxicon; 1998 Nov; 36(11):1523-8. PubMed ID: 9792168 [TBL] [Abstract][Full Text] [Related]
17. Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab')2 extrusion mechanism from blood to tissues. Sevcik C; D'Suze G; Díaz P; Salazar V; Hidalgo C; Azpúrua H; Bracho N Toxicon; 2004 Dec; 44(7):731-41. PubMed ID: 15500849 [TBL] [Abstract][Full Text] [Related]
18. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom. León G; Stiles B; Alape A; Rojas G; Gutiérrez JM Am J Trop Med Hyg; 1999 Aug; 61(2):266-71. PubMed ID: 10463678 [TBL] [Abstract][Full Text] [Related]
19. High resolution fluorescence microscopy evidence on the transport of immunoglobulins. Differences between mammalian IgG, F(ab')2 and avian IgY. Sevcik C; Salazar V; Díaz P; D'Suze G; Vázquez H Toxicon; 2013 Mar; 63():7-18. PubMed ID: 23159396 [TBL] [Abstract][Full Text] [Related]
20. Mortality and antibody responses of mice to three successive episodes of experimental scorpion (Centruroides limpidus limpidus) envenomation and immunological rescue. Padilla A; Govezensky T; Possani LD; Larralde C Toxicon; 2005 Aug; 46(2):142-9. PubMed ID: 15946719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]